ZBH Stock Recent News

ZBH LATEST HEADLINES

ZBH Stock News Image - zacks.com

Investing in surgical robotics stocks like ISRG, ZBH and STXS can be profitable for investors in 2025.

zacks.com 2025 Mar 26
ZBH Stock News Image - zacks.com

Zimmer Biomet's robust Knee business appears promising. However, a dull macroeconomic condition adds to the worry.

zacks.com 2025 Mar 21
ZBH Stock News Image - zacks.com

Among Zimmer Biomet's knee solutions featured at the AAOS 2025, the newly cleared Persona Revision SoluTion Femur is expected to draw attention.

zacks.com 2025 Mar 14
ZBH Stock News Image - zacks.com

Zimmer Biomet is strategically expanding its global presence to address the huge demand in the musculoskeletal space.

zacks.com 2025 Mar 12
ZBH Stock News Image - businesswire.com

ENGLEWOOD, Colo.--(BUSINESS WIRE)--Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “Company”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (the “HSR Act”) in connection with the previously announced acquisition of Paragon 28 by Zimmer Biomet Holdings, Inc. (NYSE: ZBH) (“Zimmer Biomet”). The expiration of the waiting period under the.

businesswire.com 2025 Mar 11
ZBH Stock News Image - prnewswire.com

Booth Spotlights Comprehensive Hip Portfolio, Newly Launched Knee and Upper Extremities Reconstructive Technologies, Including Recently Cleared Persona® Revision SoluTion™ Femur, and Debut of ZBX™ Ambulatory Surgery Center Solutions WARSAW, Ind., March 10, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that it is highlighting its diverse portfolio of orthopedic and musculoskeletal innovations at the American Academy of Orthopaedic Surgeons (AAOS) 2025 Annual Meeting being held March 10-14 in San Diego.

prnewswire.com 2025 Mar 10
ZBH Stock News Image - prnewswire.com

A Revision Knee Implant Alternative for Patients with Metal Sensitivities WARSAW, Ind., March 7, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of Persona® Revision SoluTion™ Femur, a revision knee implant component offering an alternative for patients with sensitivities to certain metals.

prnewswire.com 2025 Mar 07
ZBH Stock News Image - prnewswire.com

WARSAW, Ind., March 6, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kristen Cardillo as Senior Vice President, Chief Communications Officer.

prnewswire.com 2025 Mar 06
ZBH Stock News Image - prnewswire.com

Schwarzenegger Invites People Living with Joint Pain to Join New Online Community, Share Their Stories and Connect with a Qualified Physician WARSAW, Ind. , Feb. 26, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the launch of the  You'll Be Back  campaign with the Company's Chief Movement Officer, Arnold Schwarzenegger.

prnewswire.com 2025 Feb 26
ZBH Stock News Image - zacks.com

Zimmer Biomet is suffering due to macroeconomic uncertainties, pricing pressure and unfavorable currency fluctuations.

zacks.com 2025 Feb 17
10 of 50